v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Revenues $ 135,568 $ 6,550 $ 6,678,569 $ 11,615
Cost of revenues (229,455) (5,240) (240,526) (9,292)
Gross Profit (93,887) 1,310 6,438,043 2,323
Operating expenses:        
Research and development 1,203,352 1,226,824 2,461,300 2,705,536
General and administrative 1,870,375 2,096,021 3,703,652 4,302,301
Legal expenses (recoveries), net (1,325) 142,542 5,525 (1,596,951)
Indirect tax expense 198,146
Total operating expenses 3,072,402 3,465,387 6,368,623 5,410,886
Operating income (loss) (3,166,289) (3,464,077) 69,420 (5,408,563)
Interest expense (100,541) (228,714) (209,815) (505,853)
Change in fair value of warrant liability (2,443,335) (1,775,992)
Change in fair value of investment, net 1,748,688 1,748,688
Gain on extinguishment of liability 483,383 483,383
Other income, net 7,551 16,373 16,439 41,122
Net loss before income taxes (5,219,231) (1,927,730) (1,416,565) (4,124,606)
Income tax expense (330,186)
Net loss (5,219,231) (1,927,730) (1,746,751) (4,124,606)
Equity dividend to investor (10,154,642) (10,153,799) (11,643,114) (10,153,799)
Net loss attributable to Common Stockholders $ (15,373,873) $ (12,081,529) $ (13,389,865) $ (14,278,405)
Net loss per share, basic $ (11.58) $ (40.72) $ (11.98) $ (59.14)
Net loss per share, diluted $ (11.58) $ (40.72) $ (11.98) $ (59.14)
Weighted average shares outstanding - diluted 1,327,966 296,686 1,117,350 241,417
Weighted average shares outstanding, diluted 1,327,966 296,686 1,117,350 241,417